Can an experimental pill lift the fog of severe depression? a new trial puts KH607 to the test.

This phase 2 trial is evaluating whether an experimental drug called KH607 can safely reduce symptoms of depression in adults with moderate or severe major depressive disorder. The study has two parts: first, all participants receive KH607 openly to check safety and how the drug moves through the body; then, some participants continue on KH607 while others receive a placebo, without knowing which they are taking. The main goal is to see if KH607 leads to a greater drop in depression scores compared to placebo over three weeks.